157 related articles for article (PubMed ID: 23558042)
21. Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.
Ndrepepa G; Braun S; Iijima R; Keta D; Byrne RA; Schulz S; Mehilli J; Schömig A; Kastrati A
Clin Sci (Lond); 2009 Apr; 116(8):651-8. PubMed ID: 18851714
[TBL] [Abstract][Full Text] [Related]
22. Impact of attenuated plaque as detected by intravascular ultrasound on the occurrence of microvascular obstruction after percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Shiono Y; Kubo T; Tanaka A; Tanimoto T; Ota S; Ino Y; Aoki H; Ozaki Y; Orii M; Shimamura K; Ishibashi K; Yamano T; Yamaguchi T; Hirata K; Imanishi T; Akasaka T
JACC Cardiovasc Interv; 2013 Aug; 6(8):847-53. PubMed ID: 23871509
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Goto K; Lansky AJ; Nikolsky E; Fahy M; Feit F; Ohman EM; White HD; Mehran R; Bertrand ME; Desmet W; Hamon M; Stone GW
JACC Cardiovasc Interv; 2011 Jul; 4(7):769-77. PubMed ID: 21777885
[TBL] [Abstract][Full Text] [Related]
24. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions.
Bahrmann P; Werner GS; Heusch G; Ferrari M; Poerner TC; Voss A; Figulla HR
Circulation; 2007 Feb; 115(5):600-8. PubMed ID: 17261655
[TBL] [Abstract][Full Text] [Related]
25. [The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].
Cağli KE; Topaloğlu S; Aras D; Günel EN; Ozlü MF; Uygur B; Baysal E; Sen N
Turk Kardiyol Dern Ars; 2009 Jan; 37(1):19-25. PubMed ID: 19225249
[TBL] [Abstract][Full Text] [Related]
26. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Lincoff AM; Steinhubl SR; Manoukian SV; Chew D; Pollack CV; Feit F; Ware JH; Bertrand ME; Ohman EM; Desmet W; Cox DA; Mehran R; Stone GW;
JACC Cardiovasc Interv; 2008 Dec; 1(6):639-48. PubMed ID: 19463378
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
[TBL] [Abstract][Full Text] [Related]
28. Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: the GEPRESS study.
Palmerini T; Calabrò P; Piscione F; De Servi S; Cattaneo M; Maffeo D; Toso A; Bartorelli A; Palmieri C; De Carlo M; Capodanno D; Barozzi C; Tomasi L; Della Riva D; Mariani A; Taglieri N; Reggiani LB; Bianchi R; De Rosa R; Mariani M; Podda G; Généreux P; Stone GW; Angiolillo DJ
JACC Cardiovasc Interv; 2014 Oct; 7(10):1117-27. PubMed ID: 25240538
[TBL] [Abstract][Full Text] [Related]
29. Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
McEntegart MB; Kirtane AJ; Cristea E; Brener S; Mehran R; Fahy M; Moses JW; Stone GW
J Am Coll Cardiol; 2012 May; 59(20):1745-51. PubMed ID: 22575311
[TBL] [Abstract][Full Text] [Related]
30. [Effect of Tongxinluo on endothelial function and hypersensitive C-reactive protein in acute coronary syndrome patients undergoing percutaneous coronary intervention].
Ma Q; Zhang S; Ning Y; Pu X; Yu G; Zheng Z; Chen X; Hu K; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):550-4. PubMed ID: 19587440
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous coronary intervention in Thammasat University Hospital: the first three-year experience.
Piyayotai D; Hutayanon P
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S210-5. PubMed ID: 21294417
[TBL] [Abstract][Full Text] [Related]
32. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.
Akpek M; Kaya MG; Lam YY; Sahin O; Elcik D; Celik T; Ergin A; Gibson CM
Am J Cardiol; 2012 Sep; 110(5):621-7. PubMed ID: 22608360
[TBL] [Abstract][Full Text] [Related]
33. Effect on door-to-balloon time of immediate transradial percutaneous coronary intervention on culprit lesion in ST-elevation myocardial infarction compared to diagnostic angiography followed by primary percutaneous coronary intervention.
Plourde G; Abdelaal E; Bataille Y; MacHaalany J; Déry JP; Déry U; Larose É; De Larochellière R; Gleeton O; Barbeau G; Roy L; Costerousse O; Bertrand OF
Am J Cardiol; 2013 Mar; 111(6):836-40. PubMed ID: 23313341
[TBL] [Abstract][Full Text] [Related]
34. Amount of ST wave resolution in patients with and without spontaneous coronary reperfusion in the infarct -related artery after primary PCI: an observational study.
Erden EC; Erden I; Türker Y; Aslantaş Y; Yalçın S; Karabacak A
Anadolu Kardiyol Derg; 2012 Feb; 12(1):30-4. PubMed ID: 22214740
[TBL] [Abstract][Full Text] [Related]
35. Influence of percutaneous coronary intervention on coronary microvascular resistance index.
Verhoeff BJ; Siebes M; Meuwissen M; Atasever B; Voskuil M; de Winter RJ; Koch KT; Tijssen JG; Spaan JA; Piek JJ
Circulation; 2005 Jan; 111(1):76-82. PubMed ID: 15611371
[TBL] [Abstract][Full Text] [Related]
36. Different impacts of C-reactive protein and lipid profile on coronary lesions following a percutaneous coronary intervention.
Xu HY; Qiao SB; Zhang JF; Dong QT; Li JJ
Coron Artery Dis; 2012 May; 23(3):181-7. PubMed ID: 22336660
[TBL] [Abstract][Full Text] [Related]
37. The value of ST-segment elevation in lead aVR for predicting left main coronary artery lesion in patients suspected of acute coronary syndrome.
Nough H; Jorat MV; Varasteravan HR; Ahmadieh MH; Tavakkolian N; Sheikhvatan M
Rom J Intern Med; 2012; 50(2):159-64. PubMed ID: 23326960
[TBL] [Abstract][Full Text] [Related]
38. Level of high-sensitivity C-reactive protein is predictive of 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
Yip HK; Hang CL; Fang CY; Hsieh YK; Yang CH; Hung WC; Wu CJ
Chest; 2005 Mar; 127(3):803-8. PubMed ID: 15764760
[TBL] [Abstract][Full Text] [Related]
39. Negative Association of Circulating MicroRNA-126 with High-sensitive C-reactive Protein and Vascular Cell Adhesion Molecule-1 in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention.
Wang JN; Yan YY; Guo ZY; Jiang YJ; Liu LL; Liu B
Chin Med J (Engl); 2016 Dec; 129(23):2786-2791. PubMed ID: 27900989
[TBL] [Abstract][Full Text] [Related]
40. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
Almagor M; Keren A; Banai S
Am Heart J; 2003 Feb; 145(2):248-53. PubMed ID: 12595841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
